Канал: AlphaWatch

The Doctor is IN | November 2024 Call Recording

The Doctor is IN | November 2024 Call Recording

A Follow-Up Visit with the Doctor | September 2024 Biotech Market Insights with Mark Charest, PhD

A Follow-Up Visit with the Doctor | September 2024 Biotech Market Insights with Mark Charest, PhD

A Follow-Up Visit with the Doctor | August 2024 Biotech Market Insights with Mark Charest, PhD

A Follow-Up Visit with the Doctor | August 2024 Biotech Market Insights with Mark Charest, PhD

A Follow-Up Visit with the Doctor | July 2024 Biotech Market Insights with Mark Charest, PhD

A Follow-Up Visit with the Doctor | July 2024 Biotech Market Insights with Mark Charest, PhD

Bond Loss Write-Back Analysis 101 | Garrett Smith of Garrison Point Capital

Bond Loss Write-Back Analysis 101 | Garrett Smith of Garrison Point Capital

A Follow-Up Visit with the Doctor | May 2024 Biotech Market Insights with Mark Charest, PhD

A Follow-Up Visit with the Doctor | May 2024 Biotech Market Insights with Mark Charest, PhD

A Follow-Up Visit with the Doctor | March 2024 Biotech Market Insights with Mark Charest, PhD

A Follow-Up Visit with the Doctor | March 2024 Biotech Market Insights with Mark Charest, PhD

Spending Time with Garrett Smith | Q&A on the Residential Housing Debt Market

Spending Time with Garrett Smith | Q&A on the Residential Housing Debt Market

A Follow-Up Visit with the Doctor | February 2024 Biotech Market Insights with Mark Charest, PhD

A Follow-Up Visit with the Doctor | February 2024 Biotech Market Insights with Mark Charest, PhD

A Follow-Up Visit with the Doctor | January 2024 Biotech Market Insights with Mark Charest, PhD

A Follow-Up Visit with the Doctor | January 2024 Biotech Market Insights with Mark Charest, PhD

Spending Time with Brian Gahsman | Q&A | 2023 Robotics & Automation Wrap-up | 2024 Outlook

Spending Time with Brian Gahsman | Q&A | 2023 Robotics & Automation Wrap-up | 2024 Outlook

Spending Time with Russ Kellites | End of Year Check-in on the Volatility Market

Spending Time with Russ Kellites | End of Year Check-in on the Volatility Market

The Doctor is IN | Holiday House Call | December 2023

The Doctor is IN | Holiday House Call | December 2023

Spending Time with Brian Loo | Q&A on the Fixed Income Market

Spending Time with Brian Loo | Q&A on the Fixed Income Market

Spending Time with Mark Charest | A 911 Call to the Doctor: XBI Drop

Spending Time with Mark Charest | A 911 Call to the Doctor: XBI Drop

A Follow-Up Visit with the Doctor | October 2023 Biotech Market Insights with Mark Charest, PhD

A Follow-Up Visit with the Doctor | October 2023 Biotech Market Insights with Mark Charest, PhD

A Follow-Up Visit with the Doctor | Late Sept 2023 Biotech Market Insights with Mark Charest, PhD

A Follow-Up Visit with the Doctor | Late Sept 2023 Biotech Market Insights with Mark Charest, PhD

Spending Time with Michael Rice | Who are LifeSci Partners?

Spending Time with Michael Rice | Who are LifeSci Partners?

Spending Time with David Gregory | Q&A on the Commercial Real Estate Market

Spending Time with David Gregory | Q&A on the Commercial Real Estate Market

Spending Time with David Gregory | Q&A on the Residential Real Estate Market

Spending Time with David Gregory | Q&A on the Residential Real Estate Market

A Follow-Up Visit with the Doctor | September 2023 Biotech Market Insights with Mark Charest, PhD

A Follow-Up Visit with the Doctor | September 2023 Biotech Market Insights with Mark Charest, PhD

A Follow-Up Visit with the Doctor | August 2023 Biotech Market Insights with Mark Charest, PhD

A Follow-Up Visit with the Doctor | August 2023 Biotech Market Insights with Mark Charest, PhD

Spending Time with Brian Gahsman | Q&A | Robotics & Automation Investing

Spending Time with Brian Gahsman | Q&A | Robotics & Automation Investing

A Follow-Up Visit with the Doctor | July 2023 Biotech Market Insights with Mark Charest, PhD

A Follow-Up Visit with the Doctor | July 2023 Biotech Market Insights with Mark Charest, PhD

A Follow-Up Visit with the Doctor | June 2023 Biotech Market Insights with Mark Charest, PhD

A Follow-Up Visit with the Doctor | June 2023 Biotech Market Insights with Mark Charest, PhD

Spending Time with Mark Charest | Big Questions in Biotech

Spending Time with Mark Charest | Big Questions in Biotech

Spending Time with Mark Charest | Biotech IPOs and Follow-on Financing

Spending Time with Mark Charest | Biotech IPOs and Follow-on Financing

AlphaWatch Wind-up | Biotech M&A | Mark Charest, Ph.D., LifeSci Fund Management

AlphaWatch Wind-up | Biotech M&A | Mark Charest, Ph.D., LifeSci Fund Management

Spending Time with Mark Charest | Biotech M&A

Spending Time with Mark Charest | Biotech M&A

AlphaWatch Wind-up | Finding Value in the Housing Market

AlphaWatch Wind-up | Finding Value in the Housing Market

Spending Time with David Gregory | Housing

Spending Time with David Gregory | Housing

AlphaWatch Wind-up | Private REITs - Liquidity, Valuation, Flexibility

AlphaWatch Wind-up | Private REITs - Liquidity, Valuation, Flexibility

Spending Time with David Gregory | Private REITs

Spending Time with David Gregory | Private REITs

Market Check with David Gregory | Late November 2022 Check-Up

Market Check with David Gregory | Late November 2022 Check-Up

AlphaWatch Wind-up | Heavy Selling, Short Term, Inefficiencies & More | David Gregory

AlphaWatch Wind-up | Heavy Selling, Short Term, Inefficiencies & More | David Gregory

Spending Time with David Gregory | Real Estate: Heavy Selling, Short Term, Inefficiencies & More

Spending Time with David Gregory | Real Estate: Heavy Selling, Short Term, Inefficiencies & More

AlphaWatch Wind-up | Biotech IPOs & Alzheimer Drugs | Mark Charest, Ph.D., LifeSci Fund Management

AlphaWatch Wind-up | Biotech IPOs & Alzheimer Drugs | Mark Charest, Ph.D., LifeSci Fund Management

AlphaWatch | Spending Time with Mark Charest | Biotech IPOs and Alzheimer Treatment Drugs

AlphaWatch | Spending Time with Mark Charest | Biotech IPOs and Alzheimer Treatment Drugs

AlphaWatch Wind-up | Real-Estate Investing | David Gregory, Goshen Rock Capital

AlphaWatch Wind-up | Real-Estate Investing | David Gregory, Goshen Rock Capital

AlphaWatch | Spending Time with David Gregory of Goshen Rock Capital

AlphaWatch | Spending Time with David Gregory of Goshen Rock Capital

AlphaWatch Wind-up | Talking Commodities | Tim Rudderow and Dave Aspell, Mt Lucas Management

AlphaWatch Wind-up | Talking Commodities | Tim Rudderow and Dave Aspell, Mt Lucas Management

AlphaWatch | A Timely Tête-à-Tête with Tim Rudderow and Dave Aspell

AlphaWatch | A Timely Tête-à-Tête with Tim Rudderow and Dave Aspell

AlphaWatch Wind-up | What's Going on in Biotech? | Mark Charest, LifeSci Fund Management

AlphaWatch Wind-up | What's Going on in Biotech? | Mark Charest, LifeSci Fund Management

AlphaWatch | A Timely Tête-à-Tête with Mark Charest

AlphaWatch | A Timely Tête-à-Tête with Mark Charest

Welcome to AlphaWatch

Welcome to AlphaWatch